STOCK TITAN

Sonendo, Inc. to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Sonendo, Inc. (NYSE: SONX), a dental technology leader, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13 at 2:55 p.m. ET. An audio webcast of the presentation will be accessible via the company’s website. Sonendo is known for its GentleWave® System, which treats tooth decay using innovative technology that preserves tooth structure while enhancing clinical outcomes.

The GentleWave System improves cleaning efficacy, healing rates, and minimizes post-operative pain, thus optimizing workflow for dental practices.

Positive
  • None.
Negative
  • None.

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference. Management is scheduled to present on Tuesday, September 13 at 2:55 p.m. Eastern Time. An audio webcast of the presentation will be available on the “Investors” section of the company’s website at: investor.sonendo.com.

About Sonendo

Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices.

Sonendo is also the parent company of TDO® Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.

For more information about Sonendo and the GentleWave System, please visit www.sonendo.com. To find a GentleWave doctor in your area, please visit www.gentlewave.com.

Investor Contact:

Michael Watts

mwatts@sonendo.com

Source: Sonendo, Inc.

FAQ

When is Sonendo's presentation at the Morgan Stanley Global Healthcare Conference?

Sonendo's presentation is scheduled for September 13 at 2:55 p.m. ET.

What is the GentleWave System developed by Sonendo?

The GentleWave System is an innovative technology that treats tooth decay by cleaning and disinfecting the microscopic spaces within teeth, preserving tooth structure.

How does the GentleWave System compare to conventional root canal methods?

It offers improved clinical outcomes, superior cleaning, faster healing rates, and minimal post-operative pain compared to conventional methods.

Where can I find the webcast for Sonendo's presentation?

The webcast will be available on the 'Investors' section of Sonendo's website.

What are the key benefits of the GentleWave System?

Key benefits include better cleaning independence of tooth anatomy, high healing rates, and enhanced workflow for dental practices.

SONENDO INC

OTC:SONX

SONX Rankings

SONX Latest News

SONX Stock Data

1.28M
228.25k
0.5%
Medical Devices
Healthcare
Link
United States of America
Laguna Hills